drugset

drugset / Trial / NCT02369471

A Study of GWP42006 in People With Focal Seizures - Part A

NCT02369471 ↗

Phase 2 Completed 32 enrolled Jazz Pharmaceuticals

RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the pharmacokinetics, safety and tolerability of GWP42006 compared with placebo, in the presence of other antiepileptic drugs (AEDs).

Timeline

Start: 2015-03
Primary completion: 2015-10
Completion: 2015-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cannabidivarin	Small molecule	400 mg	—

Indications